KILITCH - Kilitch Drugs India

Kilitch Drugs India

KILITCH · Pharma > Pharmaceuticals & Drugs · MD: Mukund P Mehta · Listing date: Sept. 29, 2010 · Employees: 123 · Mumbai · http://www.kilitch.com

Stock Price vs Company Growth

4.2%

14.5%

2.3%

6.5%

20.7%

13.7%

32.4%

10y

24.1%

all

11.2%

🤔 How to analyze this graph?

Last Traded Price

₹ 356 4.2%

311

405

Company Overview

Sales

209 Cr

Growth: 25.1%

Profit after Tax

27.6 Cr

Growth: -1.5%

Small Cap

622 Cr

P/E: 20.9x

Industry P/E: 29.4x

Fundamentals

Sales (Cr)	₹ 209
Growth	25.1%
EBITDA	15.1%
P/S	3.0x
Dividend	0.0%
P/E	20.9x
Book Value	₹ 123
PEG Ratio	0.8x
ROE	13.5%
P/B	2.9x

Shareholding Pattern

Institutions

Dipak Kanayalal Shah

2.65 %

Iepf

1.5 %

Llp

0.05 %

Promoters

Kilitch Company (Pharma) Limited

42.6 %

Bhavin Mukund Mehta

12.87 %

Neeta Mukund Mehta

7.14 %

Mukund Mehta

5.72 %

Others

Increase Decrease No change

Company Profile Detailed

Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms. With nearly two decades of creating safe pharmaceutical solutions and the ultimate purpose of making the world a healthier place.Kilitch is one of the largest manufacturers of antibacterial parenteral formulations. It is also one of the largest producers of sterile liquid formulations in small volumes in India.

Investors (27)

dipak.ka...

dipak.sh...

mukund.p...

Followers (2)

paras5

varsha96